Back to newsroom

Almirall PROSES study demonstrates appropriate acne treatment decreases the burden of impact on acne sufferers’ social and emotional wellbeing

21 October 2022
  • The Patient Reported Outcomes for Sarecycline Effectiveness and Safety (PROSES) study results show significant improvement in certain health-related quality of life measures for acne patients during 12-week treatment

Back to newsroom

View all press